Related Experiment Video
Updated: Aug 4, 2026

08:25
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
Ranking radiotherapy treatment plans using decision-analytic and heuristic techniques
1Institute for Biomedical Computing, Washington University School of Medicine, St. Louis, MO 63110.
Proceedings. Symposium on Computer Applications in Medical Care
|January 1, 1991
Summary
This study introduces a novel plan-ranking model for radiotherapy treatment optimization. It uses multiattribute decision theory to rank treatment plans, improving patient care and physician preferences.
Area of Science:
- Medical Physics
- Decision Science
Background:
- Radiotherapy treatment optimization involves balancing conflicting objectives.
- Evaluating potential treatment plans requires making tradeoffs.
Purpose of the Study:
- To develop a plan-ranking model for radiotherapy treatment optimization.
- To incorporate patient-specific factors and physician preferences into treatment selection.
Main Methods:
- Utilized multiattribute decision theory for evaluating tradeoffs.
- Developed a plan-ranking model using heuristics for clinical relevance.
- Computed a figure of merit for each treatment plan.
Main Results:
- The model successfully ranks tentative treatment plans from best to worst.
- The figure of merit can serve as an objective function for automated plan generation.
Conclusions:
- The developed model offers a generalizable framework for optimizing treatment plans in radiotherapy.
- This approach can enhance clinical decision-making and potentially automate treatment planning.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...

